These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 12689521)
1. A simple ELISA for screening ligands of peroxisome proliferator-activated receptor-gamma. Cho MC; Lee HS; Kim JH; Choe YK; Hong JT; Paik SG; Yoon DY J Biochem Mol Biol; 2003 Mar; 36(2):207-13. PubMed ID: 12689521 [TBL] [Abstract][Full Text] [Related]
2. A simple method to screen ligands of peroxisome proliferator-activated receptor delta. Cho MC; Yoon HE; Kang JW; Park SW; Yang Y; Hong JT; Song EY; Paik SG; Kim SH; Yoon DY Eur J Pharm Sci; 2006 Dec; 29(5):355-60. PubMed ID: 16930961 [TBL] [Abstract][Full Text] [Related]
3. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Krey G; Braissant O; L'Horset F; Kalkhoven E; Perroud M; Parker MG; Wahli W Mol Endocrinol; 1997 Jun; 11(6):779-91. PubMed ID: 9171241 [TBL] [Abstract][Full Text] [Related]
4. A regulatory role for RIP140 in nuclear receptor activation. Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662 [TBL] [Abstract][Full Text] [Related]
6. Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators. Lazennec G; Canaple L; Saugy D; Wahli W Mol Endocrinol; 2000 Dec; 14(12):1962-75. PubMed ID: 11117527 [TBL] [Abstract][Full Text] [Related]
7. Optimization of an enzyme-linked immunosorbent assay to screen ligand of Peroxisome proliferator-activated receptor alpha. Cho MC; Lee S; Choi HS; Yang Y; Tae Hong J; Kim SJ; Yoon DY Immunopharmacol Immunotoxicol; 2009; 31(3):459-67. PubMed ID: 19263263 [TBL] [Abstract][Full Text] [Related]
8. STAT5b down-regulates peroxisome proliferator-activated receptor alpha transcription by inhibition of ligand-independent activation function region-1 trans-activation domain. Zhou YC; Waxman DJ J Biol Chem; 1999 Oct; 274(42):29874-82. PubMed ID: 10514468 [TBL] [Abstract][Full Text] [Related]
9. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators. Westin S; Kurokawa R; Nolte RT; Wisely GB; McInerney EM; Rose DW; Milburn MV; Rosenfeld MG; Glass CK Nature; 1998 Sep; 395(6698):199-202. PubMed ID: 9744281 [TBL] [Abstract][Full Text] [Related]
17. Conserved amino acids in the ligand-binding and tau(i) domains of the peroxisome proliferator-activated receptor alpha are necessary for heterodimerization with RXR. Gorla-Bajszczak A; Juge-Aubry C; Pernin A; Burger AG; Meier CA Mol Cell Endocrinol; 1999 Jan; 147(1-2):37-47. PubMed ID: 10195690 [TBL] [Abstract][Full Text] [Related]
18. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Schoonjans K; Staels B; Auwerx J Biochim Biophys Acta; 1996 Jul; 1302(2):93-109. PubMed ID: 8695669 [TBL] [Abstract][Full Text] [Related]
19. Epitope analysis of PPARgamma monoclonal antibody Pgamma48.34A and its application for screening PPARgamma ligands. Lee HS; Cho MC; Baek TW; Choe YK; Kim JW; Hong JT; Myung PK; Paik SG; Yoon DY J Immunol Methods; 2005 Jan; 296(1-2):125-34. PubMed ID: 15680157 [TBL] [Abstract][Full Text] [Related]
20. Differential activation of peroxisome proliferator-activated receptors by eicosanoids. Yu K; Bayona W; Kallen CB; Harding HP; Ravera CP; McMahon G; Brown M; Lazar MA J Biol Chem; 1995 Oct; 270(41):23975-83. PubMed ID: 7592593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]